Netherlands· NL-73d3f85541a0

Vaspit 2 mg filmomhulde tabletten

A pitavastatin product containing pitavastatine calcium, registered in Netherlands by Medochemie Limited. The same ATC class is registered in 12 of our 19 countries.

ATC C10AA08

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about pitavastatine calciumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Pitavastatin is registered in 12 of 19 countries.

Countries holding a registration under ATC C10AA08 (pitavastatin), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search pitavastatin products by name

Pitavastatin · ATC C10AA08

12 / 19 countries

Belgiumprice
Czechiaprice
Finlandprice
Franceprice
Germany
Ireland
Netherlands
Norwayprice
Polandprice
Spainprice
Switzerlandprice
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pitavastatin costs, country by country.

Normalised to the WHO defined daily dose (2 mg), the median price runs from $0.43 in Spain to $3.35 in United States — a ×7.7 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Pitavastatin · price per daily dose (2 mg)

USD · FX 28 Sept 2026

US United States$3.35 (acquisition cost)
CH Switzerland$1.57
ES Spain$0.43

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: PITAVASTATINE CALCIUM
Manufacturer: Medochemie Limited
Country: Netherlands (NL)
ATC code: C10AA08
ATC class: Pitavastatin
Defined daily dose: 2 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
129349

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

116 interactions on record for pitavastatin.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check pitavastatin against other medicines How interaction checks work

Pitavastatin · interactions on record

116 records

7 severe
103 moderate
2 minor

Most severe, free to view

ErythromycinJ01FA01severe
LeflunomidL04AA13severe
TeriflunomidL04AA31severe
CiclosporinL04AD01severe

4 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pitavastatin in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pitavastatin products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

Austria · Trolise
Bulgaria · Липоканте, Питавиа
Cyprus · Vaspit
Czechia · Pitilox
Germany · Livazo, Pitavastatin
Spain · Alipza, Lipix
France · Lippiza, Trolise
Greece · Fiarat, Livazo
Hungary · Pitilox
Ireland · Livazo
Italy · Livazo
Lithuania · Pitipix
Malta · Vaspit
Norway · Livazo
Poland · Livazo, Pitamet
Portugal · Alipza, Livazo
Romania · Pitipix
Slovenia · Pitipix
Slovakia · Pitipix

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f1a16c90-658f-42fa-8232-cd7c6b3c6a64
GET /v1/drugs/f1a16c90-658f-42fa-8232-cd7c6b3c6a64?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h129349_smpc_en.pdf",
  "strength": null,
  "atc_label": "Pitavastatin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg129349",
  "excipients": [
    "HYDROXYPROPYLCELLULOSE, LAAG GESUBSTITUEERD (E 463a)",
    "HYPROMELLOSE (E 464)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "LACTOSE 1-WATER",
    "MAGNESIUMALUMINOMETASILICAAT",
    "MAGNESIUMSTEARAAT (E 470b)",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)",
    "TRIETHYLCITRAAT (E 1505)"
  ],
  "substances": [
    "PITAVASTATINE CALCIUM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h129349_piluk.pdf",
  "authorised_at": "2023/03/27",
  "procedure_number": "NL/H/5522/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "129349",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about pitavastatin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console